Given the low number of subjects and CV events for subjects without established CVD in both analyses, however, these results should be interpreted with caution
As this is a phase 2 trial, the full long-term safety profile of retatrutide has not yet been established
Smaller portions also feel filling sooner as stomach emptying slows
However, it is important to consider our study period and the recent launch of the 3.0 mg and 4.5 mg dosage formulations in France in July 2021, as well as the coronavirus disease (COVID-19) pandemic, which decreased access to primary care access and may have potentially lessened the likelihood of initiating new dosage formulations in patients [16, 17]
[7] Start gradually if you are not currently active, and consult your healthcare team before beginning any new exercise programme
Recipient factors in faecal microbiota transplantation: one stool does not fit all